SE418573B - Sett att framstella ett vaccin - Google Patents
Sett att framstella ett vaccinInfo
- Publication number
- SE418573B SE418573B SE7414326A SE7414326A SE418573B SE 418573 B SE418573 B SE 418573B SE 7414326 A SE7414326 A SE 7414326A SE 7414326 A SE7414326 A SE 7414326A SE 418573 B SE418573 B SE 418573B
- Authority
- SE
- Sweden
- Prior art keywords
- vaccin
- make
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/13—Poliovirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/205—Rhabdoviridae, e.g. rabies virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/10011—Arenaviridae
- C12N2760/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/10011—Arenaviridae
- C12N2760/10051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20111—Lyssavirus, e.g. rabies virus
- C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20111—Lyssavirus, e.g. rabies virus
- C12N2760/20151—Methods of production or purification of viral material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Pulmonology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU7301967101A SU579309A1 (ru) | 1973-11-16 | 1973-11-16 | Способ получени вакцины |
Publications (2)
Publication Number | Publication Date |
---|---|
SE7414326L SE7414326L (de) | 1975-05-20 |
SE418573B true SE418573B (sv) | 1981-06-15 |
Family
ID=20566763
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7414326A SE418573B (sv) | 1973-11-16 | 1974-11-14 | Sett att framstella ett vaccin |
Country Status (9)
Country | Link |
---|---|
US (1) | US4071619A (de) |
CS (1) | CS172111B1 (de) |
DD (1) | DD114615A1 (de) |
DE (1) | DE2452919C3 (de) |
FR (1) | FR2251334B1 (de) |
GB (1) | GB1446107A (de) |
HU (1) | HU175489B (de) |
SE (1) | SE418573B (de) |
SU (1) | SU579309A1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4328208A (en) * | 1981-05-20 | 1982-05-04 | Kurbanov Ildus A | Vaccine against chlamydous infections of farm animals |
US4880512A (en) * | 1984-02-16 | 1989-11-14 | Kollmorgen Corporation | Pulsed light selective photolysis process for treatment of biological media and products made thereby |
JPS60197629A (ja) * | 1984-03-16 | 1985-10-07 | Chemo Sero Therapeut Res Inst | HBs抗原の精製方法 |
JPS6176160A (ja) * | 1984-09-21 | 1986-04-18 | 松永 是 | 殺細胞方法 |
GB9018690D0 (en) * | 1990-08-24 | 1990-10-10 | Wellcome Found | Vaccines |
US5639461A (en) * | 1994-09-30 | 1997-06-17 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Influenza machine |
CN102985536B (zh) | 2010-04-14 | 2017-12-05 | Emd密理博公司 | 生产高效价、高纯度的病毒母液的方法及使用其的方法 |
-
1973
- 1973-11-16 SU SU7301967101A patent/SU579309A1/ru active
-
1974
- 1974-11-07 DE DE2452919A patent/DE2452919C3/de not_active Expired
- 1974-11-13 CS CS7739A patent/CS172111B1/cs unknown
- 1974-11-14 GB GB4932374A patent/GB1446107A/en not_active Expired
- 1974-11-14 SE SE7414326A patent/SE418573B/xx unknown
- 1974-11-14 DD DD182362A patent/DD114615A1/xx unknown
- 1974-11-15 HU HU74LE762A patent/HU175489B/hu unknown
- 1974-11-25 FR FR7438632A patent/FR2251334B1/fr not_active Expired
-
1976
- 1976-09-02 US US05/719,692 patent/US4071619A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CS172111B1 (de) | 1976-12-29 |
SE7414326L (de) | 1975-05-20 |
SU579309A1 (ru) | 1977-11-05 |
DE2452919C3 (de) | 1981-01-22 |
FR2251334B1 (de) | 1978-07-21 |
FR2251334A1 (de) | 1975-06-13 |
GB1446107A (en) | 1976-08-11 |
US4071619A (en) | 1978-01-31 |
DE2452919B2 (de) | 1980-05-22 |
DE2452919A1 (de) | 1975-05-22 |
DD114615A1 (de) | 1975-08-12 |
HU175489B (hu) | 1980-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE420405B (sv) | Sett att framstella ett polykarboxylatcement | |
SE389690B (sv) | Sett att framstella ett vermeaterhemtbart foremal | |
SE7512087L (sv) | Sett att framstella vattensvellbar polyalkylenoxid | |
SE418671B (sv) | Sett att framstella ett proteinhaltigt fodoemne | |
SE416476B (sv) | Sett att framstella ett styvt alster | |
SE418567B (sv) | Sett att framstella ett fast proteinhaltigt fodoemne | |
SE430887B (sv) | Sett att framstella vissa substituerade fenylguanidiner | |
SE417316B (sv) | Sett att framstella piperazinyl-kinoxalin-foreningar | |
SE417089B (sv) | Sett att framstella en sulfonamidoarylforening | |
SE417507B (sv) | Sett att framstella 2-arylamino-2-imidazolinderivat | |
SE7506313L (sv) | Sett att framstella ett prostaglandinkonjugat | |
SE413598B (sv) | Sett att framstella 7-amino-delta?723-cefem-derivat | |
SE420602B (sv) | Sett att framstella pyrazin-3-metoxi-2-karboxamidderivat | |
SE7711154L (sv) | Sett att framstella en smorjmedeltillsats | |
SE418573B (sv) | Sett att framstella ett vaccin | |
SE399270B (sv) | Sett att framstella spirolaktonsteroider | |
SE405525B (sv) | Sett att framstella ett halvledaraggregat | |
SE417981B (sv) | Sett att framstella cefalosporinforeningar | |
SE396428B (sv) | Sett att framstella en filterbrunn | |
SE414179B (sv) | Sett att framstella alkylfosfiner | |
SE427655B (sv) | Sett att framstella abietamidderivat | |
SE389689B (sv) | Sett att framstella ett vermeaterhemtbart foremal | |
SE419647B (sv) | Sett att framstella tiazolisokinolinderivat | |
SE389145B (sv) | Sett att framstella en fiberprodukt | |
SE428471B (sv) | Sett att framstella imidazolderivat |